1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MACROGENICS INC
Macrogenics Inc XNAS: MGNX

Macrogenics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast...

Read More
1.80 0.04 (2.27%)
46.43% Fall from 52W High
1.1M
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
26.7 / 100
Momentum Score
Technically Neutral
51.2 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
3
1Yr Price target upside is 89%
5 analysts

19

S

9

W

1

O

2

T

SWOT Analysis

Macrogenics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..